Showing results (1-10 of 2,124) with videos related to
Sort By:
Pageof 213
Clinical and Experimental Immunology|June 11, 1999
Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cellsG Weiss, C Murr, H Zoller, et al.Archivum Immunologiae Et Therapiae Experimentalis|November 4, 2000
Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiencyB Widner, B Wirleitner, G Baier-Bitterlich, et al.Current Drug Metabolism|July 24, 2001
Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequencesB Widner, M Ledochowski, D FuchsFree Radical Research|November 5, 1999
Neopterin derivatives modulate toxicity of reactive species on Escherichia coliI Wede, B Widner, D FuchsJournal of Neural Transmission (Vienna, Austria : 1996)|June 22, 2002
Increased neopterin production and tryptophan degradation in advanced Parkinson's diseaseB Widner, F Leblhuber, D FuchsClinical Immunology (Orlando, Fla.)|January 6, 2001
Inverse relationship between neopterin and immunoglobulin EM Ledochowski, C Murr, B Widner, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 26, 1999
Association between insulin resistance, body mass and neopterin concentrationsM Ledochowski, C Murr, B Widner, et al.Biochemical and Biophysical Research Communications|August 31, 2000
Oxidation of 7,8-dihydroneopterin by hypochlorous acid yields neopterinB Widner, C Mayr, B Wirleitner, et al.Current Drug Metabolism|May 11, 2002
Neopterin as a marker for immune system activationC Murr, B Widner, B Wirleitner, et al.Advances in Experimental Medicine and Biology|March 18, 2000
An HPLC method to determine tryptophan and kynurenine in serum simultaneouslyB Widner, E R Werner, H Schennach, et al.Pageof 213